By Drug Target Review2024-02-21T12:00:42
Researchers have discovered a new pathway which seems to be a significant contributor to the development of cardiovascular disease.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2023-02-03T13:56:13
Sponsored by Leica Microsystems
2023-07-11T16:13:06
Sponsored by Agilent
2024-01-19T07:40:55
Sponsored by Euretos
2024-01-10T08:23:16
Sponsored by BellBrook Labs
2023-07-04T09:00:08
Sponsored by SB Drug Discovery
2023-03-07T10:55:58
Sponsored by Agilent
Site powered by Webvision Cloud